AK-137
- Generic Name
- AK-137
AK137 (Bispecific Antibody Targeting CD73 and LAG-3) in Patients With Advanced Malignant Tumors
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Akeso
- Target Recruit Count
- 87
- Registration Number
- NCT06691360
- Locations
- 🇨🇳
Shanghai Pulmonary Hospital, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath